A pilot study of treatment of social phobia with alprazolam.
Fourteen patients with DSM-III social phobia were treated with alprazolam in an open study. Multiple measures of symptoms and disability showed significant improvement. The symptoms improved during the first and second weeks, and disability improved at 3 weeks and beyond. After medication withdrawal the symptom and disability measures were no longer significantly different from those at baseline.
Reich
J
J
Department of Psychiatry, University of Iowa College of Medicine, Iowa City.
Yates
W
W
D000328:Adult; D000368:Aged; D000525:Alprazolam / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010554:Personality Disorders / Q000188:drug therapy / Q000523:psychology; D010555:Personality Inventory; D010698:Phobic Disorders / Q000188:drug therapy* / Q000523:psychology; D010865:Pilot Projects; D011569:Psychiatric Status Rating Scales; D013997:Time Factors
D000525:Alprazolam